Inventor · disambiguated record
Rinpei Niwa
Also filed as: NIWA RINPEI
20 granted patents·18 pending applications·384 citations·filing 2001–2023
95Inventor score
Files withKYOWA HAKKO KIRIN CO LTD13KYOWA HAKKO KOGYO KK8SHITARA KENYA6KYOWA KIRIN CO LTD5NAKAGAWA TOMOAKI2
Top patents by PatentIndex Score
38 records- 0197US7923538B2Recombinant antibody compositionKYOWA HAKKO KIRIN CO LTD·Filed 2006·Granted Apr 12, 2011·84 cites·5 claims
- 0296US6989145B2Recombinant antibody and antibody fragmentKYOWA HAKKO KOGYO KK·Filed 2001·Granted Jan 24, 2006·93 cites·37 claims
- 0395US7994290B2Effector function enhanced recombinant antibody compositionKYOWA HAKKO KIRIN CO LTD·Filed 2008·Granted Aug 9, 2011·55 cites·6 claims
- 0493US7666418B2Method for treating Th2-mediated diseaseKYOWA HAKKO KIRIN CO LTD·Filed 2005·Granted Feb 23, 2010·22 cites·32 claims
- 0591US8399621B2Anti-CD4 antibodyNAKAGAWA TOMOAKI·Filed 2009·Granted Mar 19, 2013·16 cites·11 claims
- 0690US7691568B2Antibody composition-containing medicamentKYOWA HAKKO KIRIN CO LTD·Filed 2003·Granted Apr 6, 2010·39 cites·5 claims
- 0789US7438911B2Antibody against human insulin-like growth factorKYOWA HAKKO KOGYO KK·Filed 2003·Granted Oct 21, 2008·33 cites·13 claims
- 0888US9556279B2Antibody variants compositionNIWA RINPEI·Filed 2011·Granted Jan 31, 2017·17 cites·4 claims
- 0982US9714291B2Heterodimer protein compositionKYOWA HAKKO KIRIN CO LTD·Filed 2013·Granted Jul 25, 2017·5 cites·17 claims
- 1082US8632996B2Method for producing recombinant antibody and antibody fragment thereofSHITARA KENYA·Filed 2012·Granted Jan 21, 2014·4 cites·28 claims
- 1181US8883981B2Recombinant antibody compositionSHITARA KENYA·Filed 2010·Granted Nov 11, 2014·3 cites·6 claims
- 1279US10494437B2Heterodimer protein compositionKYOWA HAKKO KIRIN CO LTD·Filed 2017·Granted Dec 3, 2019·2 cites·19 claims
- 1379US8197814B2Method for treating the Th2-mediated diseaseSHITARA KENYA·Filed 2010·Granted Jun 12, 2012·3 cites·32 claims
- 1477US8877913B2Anti-CD4 antibodyNAKAGAWA TOMOAKI·Filed 2013·Granted Nov 4, 2014·2 cites·4 claims
- 1577US2024059788A1BISPECIFIC ANTIBODY WHICH BINDS TO CD40 AND EpCAMKYOWA KIRIN CO LTD·Filed 2023·Application pending·0 cites
- 1676US8491902B2Medicament comprising recombinant antibody against chemokine receptor CCR4SHITARA KENYA·Filed 2004·Granted Jul 23, 2013·6 cites·17 claims
- 1766US9475886B2Recombinant antibody compositionKYOWA HAKKO KIRIN CO LTD·Filed 2014·Granted Oct 25, 2016·0 cites·8 claims
- 1865US11773180B2Bispecific antibody which binds to CD40 and EpCAMKYOWA KIRIN CO LTD·Filed 2018·Granted Oct 3, 2023·0 cites·18 claims
- 1964US2010150917A1Method of Depleting Regulatory T CellKYOWA HAKKO KIRIN CO LTD·Filed 2009·Application pending·0 cites
- 2062US9675625B2Medicament comprising recombinant antibody against chemokine receptor CCR4KYOWA HAKKO KIRIN CO LTD·Filed 2013·Granted Jun 13, 2017·0 cites·18 claims
- 2162US2009226399A1Medicaments comprising gene recombinant antibody against ganglioside gd3KYOWA HAKKO KIRIN CO LTD·Filed 2009·Application pending·0 cites
- 2261US2008166345A1Medicaments comprising gene recombinant antibody against ganglioside gd3KYOWA HAKKO KOGYO KK·Filed 2008·Application pending·0 cites
- 2360US10040861B2Antibody variants compositionKYOWA HAKKO KIRIN CO LTD·Filed 2016·Granted Aug 7, 2018·0 cites·16 claims
- 2460US2005226867A1IL-5R-specific antibody compositionKYOWA HAKKO KOGYO KK·Filed 2004·Application pending·0 cites
- 2559US2005287138A1CCR4-specific antibody compositionKYOWA HAKKO KOGYO KK·Filed 2004·Application pending·0 cites
- 2656US2023159662A1Antibody compositionKYOWA KIRIN CO LTD·Filed 2021·Application pending·0 cites
- 2756US2008095765A1IL-5R-specific antibody compositionKYOWA HAKKO KOGYO KK·Filed 2007·Application pending·0 cites
- 2856US2008213266A1Method for Treating CCR4-Related DiseasesKYOWA HAKKO KOGYO KK·Filed 2008·Application pending·0 cites
- 2953US2023406926A1Bispecific antibody binding to cd3KYOWA KIRIN CO LTD·Filed 2021·Application pending·0 cites
- 3053US2006034841A1Method of depleting regulatory T cellKYOWA HAKKO KOGYO KK·Filed 2005·Application pending·0 cites
- 3150US8492526B2Effector function enhanced recombinant antibody compositionSHITARA KENYA·Filed 2011·Granted Jul 23, 2013·0 cites·7 claims
- 3250US2021380684A1Antibody compositionKYOWA KIRIN CO LTD·Filed 2019·Application pending·0 cites
- 3350US2012020962A1Method of depleting regulatory t cellUEDA RYUZO·Filed 2011·Application pending·0 cites
- 3448US2011236374A1Genetically recombinant antibody composition capable of binding specifically to ganglioside gm2KYOWA HAKKO KIRIN CO LTD·Filed 2008·Application pending·0 cites
- 3548US2005260206A1Drugs containing genetically modified antibody against ganglioside gd3SHITARA KENYA·Filed 2002·Application pending·0 cites
- 3644US2009028877A1Antibody Composition Specifically Binding to Ganglioside GmIIDA SHIGERU·Filed 2004·Application pending·0 cites
- 3743US2005031613A1Therapeutic agent for patients having human FcgammaRIIIaFiled 2003·Application pending·0 cites
- 3833US2017190781A1Anti-death receptor 3 (dr3) antagonistic antibodies with reduced agonistic activityKYOWA HAKKO KIRIN CO LTD·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Rinpei Niwa files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →